van Tellingen O, van der Woude H R, Beijnen J H, Rao K S, ten Bokkel Huinink W W, Nooyen W J
Department of Clinical Chemistry, Netherlands Cancer Institute, Amsterdam.
J Chromatogr. 1990 Aug 3;529(2):329-38. doi: 10.1016/s0378-4347(00)83839-6.
A high-performance liquid chromatographic procedure, including sample pretreatment, is presented for the analysis of the experimental antitumour drug vintriptol in plasma. The sample pretreatment involved liquid-liquid extraction of the buffered (pH 3) sample with chloroform. Vinblastine was used as internal standard. Separation was achieved on a Hypersil ODS (5 microns) column with a mobile phase of acetonitrile-phosphate buffer. Electrochemical detection (at +0.70 V) was used, giving a detection limit of 2 micrograms/l. The applicability of the assay was demonstrated in a pharmacokinetic study with eight cancer patients who received 45 or 50 mg/m2 vintriptol in a phase I study. A three-compartment model was used to fit the plasma concentration-time curves. Pharmacokinetic parameters are presented.
本文介绍了一种用于分析血浆中实验性抗肿瘤药物长春曲醇的高效液相色谱法,包括样品预处理。样品预处理包括用氯仿对缓冲(pH 3)样品进行液-液萃取。以长春碱为内标。在Hypersil ODS(5微米)柱上,以乙腈-磷酸盐缓冲液为流动相进行分离。采用电化学检测(+0.70 V),检测限为2微克/升。在一项一期研究中,对8名接受45或50毫克/平方米长春曲醇的癌症患者进行的药代动力学研究证明了该测定方法的适用性。采用三室模型拟合血浆浓度-时间曲线。给出了药代动力学参数。